Immediate Impact
3 standout
Citing Papers
BRAF — a tumour-agnostic drug target with lineage-specific dependencies
2024 Standout
Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
2023 Standout
Works of Rafe Shellooe being referenced
Phase 1/2 precision medicine study of the next-generation BRAF inhibitor PLX8394.
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Rafe Shellooe | 9 | 8 | 1 | 5 | 3 | 11 | |
| Holli Carden | 11 | 4 | 1 | 3 | 2 | 14 | |
| Tycel Phillips | 10 | 5 | 4 | 3 | 15 | ||
| Mika Hakkarainen | 13 | 5 | 2 | 3 | 15 | ||
| Fazulur Rehaman Vempalli | 3 | 8 | 1 | 4 | 4 | 13 | |
| Guillermo Espino | 7 | 5 | 4 | 6 | 2 | 11 | |
| Alexandra Berninger | 8 | 5 | 1 | 2 | 3 | 13 | |
| Heidi Carias | 5 | 3 | 1 | 2 | 2 | 12 | |
| Jayant Kumar | 8 | 6 | 1 | 1 | 2 | 13 | |
| V Oktseloglou | 4 | 9 | 4 | 3 | 3 | 13 | |
| Weihong Chase | 6 | 2 | 1 | 4 | 3 | 15 |
All Works
Loading papers...